Literally a matter of getting all the ducks in a row. Merger completion, stock split, CMML treatment authorization, resubmission of EUA application from LIVE-AIR and relevant portion of ACTIV-5 results, study on the sustained reduction in cytokine levels, maybe an update on Long Covid treatment progress, etc. Optimistic, but not "patiently optimistic." It will be one thing after another from the management team, and may get into news on the arthritis/asthma indications.
They deserve the success, and so do the shareholders.
News 
Market Data 
Discover 
